Synergism of CTLA4-IG and Anti-CD4 Monoclonal Antibody Treatment in a Rat Kidney Transplant Model

By Graser E.   Risch K.   Linsley P.S.   Hancock W.W.   Muller A.   Brock J.   Reinke P.   Kupiec-Weglinski J.W.   Volk H.D.   Lehmann M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1307-1309

Elsevier

Access to resources Recommend Favorite

Anti-CD44 Monoclonal Antibody Inhibits Heart Transplant Rejection Mediated by Alloantigen-primed CD4⁺ Memory T Cells in Nude Mice

By Wang Feng   Chen Jibing   Shao Wei   Xie Baiyi   Wang Yongzhi   Lan Tianshu   Thorlacius Henrik   Qi Zhongquan  

Immunological Investigations, Vol. 39, Iss. 8, 2010-01 ,pp. : 807-819

Informa Healthcare

Access to resources Recommend Favorite

Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients

By Sterkers G.   Baudouin V.   Ansart-Pirenne H.   Maisin A.   Niaudet P.   Cochat P.   Loirat C.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2757-2759

Elsevier

Access to resources Recommend Favorite

Prevention of Heart Allograft and Kidney Xenograft Rejection by Monoclonal Antibody to CD45RB

By Zhang Z.   Zhong R.   Jiang J.   Wang J.   Garcia B.   Le Feuvre C.   White M.   Stiller C.   Lazarovits A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1253-1253

Elsevier

Access to resources Recommend Favorite

Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4 + /CD45RA + Cells in Patients with Rheumatoid Arthritis

By van der Lubbe P.A.   Breedveld F.C.   Tak P.P.   Schantz A.   Woody J.   Miltenburg A.M.M.  

Journal of Autoimmunity, Vol. 10, Iss. 1, 1997-01 ,pp. : 87-97

Academic Press

Access to resources Recommend Favorite